OECD insights blog: Francesca Colombo, Head of the OECD Health Division, discusses the issues related to health systems and an ageing population.
The OECD launched a project on “Benchmarking ICTs in health systems”, a multi-stakeholder initiative to improve the availability and quality of health ICT data through the development of a robust measurement framework and comparable cross-national measures. This task was accomplished in 2013 with the publication of an OECD “Guide to Measuring ICTs in the Health Sector”.
The Working Paper sheds light on the extent to which “value” is considered in pricing and/or coverage decisions in 14 OECD member countries. It describes methods used by countries to assess the therapeutic benefits of new products, as well as approaches for economic evaluation, where relevant, and aims to illustrate how value is assessed and what is its impact on pricing and/or reimbursement decisions.
Dementia is a devastating condition for the people affected, their family and friends, and for health systems. Through its global reach and ability to bring together government and non-government perspectives, OECD is in a unique position to face up to the challenge.
The large and growing human and financial cost of dementia provides an imperative for policy action. It is already the second largest cause of disability for the over-70s and it costs $645bn per year globally, and ageing populations mean that these costs will grow.
There is no cure or effective treatment for dementia, and too often people do not get appropriate health and care services, leading to a poor quality of life. Our failure to tackle these issues provides a compelling illustration of some of today’s most pressing policy challenges. We need to rethink our research an innovation model, since progress on dementia has stalled and investment is just a fraction of what it is for other diseases of similar importance and profile. But even then a cure will be decades away, so we need better policies to improve the lives of people living with dementia now. Communities need to adjust to become more accommodating of people with dementia and families who provide informal care must be better supported. Formal care services and care institutions need to promote dignity and independence, while coordination of health and care services must be improved. But there is hope: if we can harness big data we may be able to address the gaps in our knowledge around treatment and care.
OECD countries are developing strategies to improve the quality of life of those affected by dementia and to support long-term efforts for a disease-modifying therapy or cure. The OECD jointly hosted an international workshop in Toronto with the Ontario Brain Institute (OBI) and the Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto on 14-15 September 2014. The aim of the workshop was to advance international discussion of the opportunities and challenges, as well as successful strategies, for sharing and linking the massive amounts of population-based health and health care data that are routinely collected (broad data) with detailed clinical and biological data (deep data) to create an international resource for research, planning, policy development, and performance improvement. The workshop brought together leading researchers and academics, industry and non-government experts to provide new insights into the opportunities and challenges in making “broad and deep” data a reality – from funding to data standards, to data sharing, to new analytics, to protecting privacy, and to engaging with stakeholders and the public. Government leadership and public-private partnership will be needed to create and sustain big data resources, including financing for data infrastructure and incentives for data sharing.
Au cours des dernières décennies, l’Italie a considérablement amélioré la qualité de ses soins de santé, mais elle doit encore réduire les fortes disparités régionales qui subsistent, selon une nouvelle étude de l’OCDE.
How health providers are paid is one of the key policy levers that countries have to drive health system performance. The 2012 HSC Survey analyses the payment modes currently in use in OECD countries to remunerate primary care, outpatient specialist care and inpatient care, the price regulations for health services and identifies new innovative modes of payments in more detail.
English, PDF, 271kb
Despite cuts in recent years, health spending as a share of GDP in Ireland remains slightly higher than the EU average and pharmaceutical spending in particular remains relatively high.
English, PDF, 290kb
Le poids des dépenses hospitalières dans les dépenses de santé s’avère très élevé en France malgré des efforts pour développer des modes de prise en charge moins coûteux.